Skip to main content

Prescription medicine

Anhydrous dextrose, calcium chloride and 5 other ingredients Brand names: Elliotts

Anhydrous dextrose, calcium chloride and 5 other ingredients (Elliotts) is a prescription medicine. No generic is listed in FDA's NDC Directory.

  • No generic listed

Check it at the source: the anhydrous dextrose, calcium chloride and 5 other ingredients FDA label on DailyMed (effective October 16, 2024); every anhydrous dextrose, calcium chloride and 5 other ingredients label on DailyMed.

Highlights of the record

FDA label of October 16, 2024; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026

Used for

From the label: indications and usage

Elliotts B Solution is indicated as a diluent for the intrathecal administration of methotrexate sodium and cytarabine for the prevention or treatment of meningeal leukemia or lymphocytic lymphoma.

Forms and strengths

  • 73 mg/10ml / 19 mg/10ml / 8 mg/10ml / 3 mg/10ml / 3 mg/10ml / 2 mg/10ml / 2 mg/10ml

Injection.

On the market

Generic approvals
No generic approved
Labelers listed (NDC)
1 of which 0 under generic applications, 1 under brand applications, repackagers included

Supply and safety

Pharmacy cost (NADAC)
Not in the survey
Shortage (FDA)
No current entry
Recalls by its makers (FDA)
No recall recorded

What is anhydrous dextrose, calcium chloride and 5 other ingredients used for?

From the label: indications and usage

Elliotts B Solution is indicated as a diluent for the intrathecal administration of methotrexate sodium and cytarabine for the prevention or treatment of meningeal leukemia or lymphocytic lymphoma.

FDA pharmacologic class: Blood Coagulation Factor, Calculi Dissolution Agent, Osmotic Laxative, Phosphate Binder and Potassium Salt.

Source: FDA drug label (Elliotts B), Lukare Medical, LLC, effective October 16, 2024 (SPL set 08036dbd-55b3-47b9-9890-000f253544f3), via openFDA; the full label on DailyMed

Is there a generic for anhydrous dextrose, calcium chloride and 5 other ingredients (Elliotts)?

No generic anhydrous dextrose, calcium chloride and 5 other ingredients is approved (Drugs@FDA, October 8, 2026).

Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)

What does the anhydrous dextrose, calcium chloride and 5 other ingredients label say about other medicines?

The anhydrous dextrose, calcium chloride and 5 other ingredients label names 2 other medicines in its interaction, contraindication or warning sections. The sentences are the labels' own; a label lists what its studies and reports found, not every interaction.

Medicine namedSectionWhat the label says
CytarabinewarningsWARNINGS Intrathecal administration of drugs such as methotrexate sodium and cytarabine should be performed by personnel skilled in the technique of lumbar puncture under the supervision of a physician who is experienced in the use of cancer chemotherapeutic agents.
MethotrexatewarningsWARNINGS Intrathecal administration of drugs such as methotrexate sodium and cytarabine should be performed by personnel skilled in the technique of lumbar puncture under the supervision of a physician who is experienced in the use of cancer chemotherapeutic agents.

Check anhydrous dextrose, calcium chloride and 5 other ingredients against other medicines

Source: FDA drug label (Elliotts B), Lukare Medical, LLC, effective October 16, 2024 (SPL set 08036dbd-55b3-47b9-9890-000f253544f3), via openFDA; the full label on DailyMed

What next?

Other blood coagulation factors
the pharmacologic class, with prices and generics
Check an interaction
what two or more labels say about each other